PROSPECTS AND OPPORTUNITIES
The ageing population will drive volume and distribution growth
Over the forecast period, sales in the RX/reimbursement adult incontinence segment are expected to experience positive growth, alongside an increase in the volume of distribution for these products. Life expectancy in Argentina has been rising steadily in recent decades and is anticipated to continue growing.
The government’s reluctance to spend on premium products will impact innovation
One of the main criticisms of the distribution of adult diapers by PAMI is the poor quality of the products. The adult diapers provided by PAMI are far from being the most advanced, with skincare not being a priority when selecting products for distribution.
The distribution of RX/Reimbursement adult incontinence products is not expected to change
The distribution of adult incontinence for older individuals has almost always been managed through pharmacies, and this system is expected to continue throughout the forecast period. This structure ensures the involvement of multiple parties in the distribution chain, including PAMI, the pharmacy chambers, and the pharmacies themselves.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Argentina with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Argentina, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Argentina report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Argentina?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Argentina?
- How are products distributed in Rx/Reimbursement adult incontinence in Argentina?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Argentina - Category analysis
KEY DATA FINDINGS
The ageing population continues to drive use of RX/reimbursement adult incontinence
Liberty SA and Nochisimo SA are authorised suppliers of RX/reimbursement adult incontinence
The government reverts back to the previous distribution system for RX/reimbursement products
The ageing population will drive volume and distribution growth
The government’s reluctance to spend on premium products will impact innovation
The distribution of RX/Reimbursement adult incontinence products is not expected to change
Tissue and Hygiene in Argentina - Industry Overview
Tissue and hygiene in 2024: The big picture
2024 key trends
Competitive landscape
Retail developments
What next for tissue and hygiene?
DISCLAIMER
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!